MLchartDataset catalogue

CP-358,774

Term · Oncology and biomedicine · MLC-T-ONC-002109

A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. CP-358,774 blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774, and Tarceva.

Table 1. Record
IdentifierMLC-T-ONC-002109
FieldOncology and biomedicine
Expansionserlotinib hydrochloride; Tarceva
SynonymsOSI-774
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002109",
  "term": "CP-358,774",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. CP-358,774 blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774, and Tarceva.",
  "expansions": [
    "erlotinib hydrochloride",
    "Tarceva"
  ],
  "synonyms": [
    "OSI-774"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cp-358774/"
}

Record 5,388 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.